AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30877851
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) with D-cycloserine augmentation
Trial: 30877851
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) with placebo augmentation
Trial: 28712074
Drug: 12.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg/day SHP465 MAS
Trial: 28712074
Drug: 37.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 37.5 mg/day SHP465 MAS
Trial: 26825824
Drug: Continuous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continuous low-dose oral cyclophosphamide 50 mg and methotrexate 2.5 mg (maintenance arm)
Trial: 24956453
Drug: GA with
RxNorm normalized name: Tums with Gas Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GA with a single‐injection TPVB and placebo paravertebral infusion
Trial: 22103956
Drug: Low-dosage control
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dosage control group workshop
Trial: 19924281
Drug: RTS,S/AS vaccines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS vaccines (pooled)
Trial: 11581040
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia without intravenous sedatives
Trial: 11581040
Drug: Injection anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection anesthesia without intravenous sedatives
Trial: 11581040
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia with intravenous sedatives
Trial: 11581040
Drug: Injection anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection anesthesia with intravenous sedatives
Trial: 11581040
Drug: Injection anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection anesthesia with short-acting hypnotic agents (alone)
Trial: 11581040
Drug: Injection anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection anesthesia with short-acting hypnotic agents (with opiates)
Trial: 11581040
Drug: Injection anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection anesthesia with short-acting hypnotic agents (with sedatives)
Trial: 11581040
Drug: Injection anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection anesthesia with short-acting hypnotic agents (with opiates and sedatives)
Trial: 9636865
Drug: Itraconazole oral
RxNorm normalized name: itraconazole Oral Tablet
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole oral solution (100 mg once daily for 14 days)
Trial: 9636865
Drug: Fluconazole capsules
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole capsules (100 mg once daily for 14 days)
Trial: 9636865
Drug: Itraconazole oral
RxNorm normalized name: itraconazole Oral Tablet
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole oral solution (100 mg twice daily for 7 days)
Trial: 3276670
Drug: Desipramine in
RxNorm normalized name: desipramine Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine in combination with methadone
Trial: 25661282
Drug: suvorexant (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: suvorexant (40 mg in <65 y-olds; 30 mg in ≥65 y-olds)
Trial: 18652757
Drug: V80/H12.5 (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: V80/H12.5 (80 mg valsartan/12.5 mg hydrochlorothiazide)
Trial: 18652757
Drug: V80 (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: V80 (80 mg valsartan)
Trial: 12664247
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral diazepam (Dz)
Trial: 10560170
Drug: Over-the-counter (OTC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Over-the-counter (OTC) use of nicotine replacement therapy
Trial: 10560170
Drug: Medical prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical prescription of nicotine substitutes
Trial: 2071269
Drug: Voltaren 'A'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voltaren 'A' (50 mg)
Trial: 2071269
Drug: Inflaban 'B'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inflaban 'B' (50 mg)
Trial: 6353620
Drug: Intravenous domperidone
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous domperidone 10 mg
Trial: 23386645
Drug: 1000 IU
RxNorm normalized name: D 1000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 IU vitamin D2 daily for 11 weeks
Trial: 23386645
Drug: 1000 IU
RxNorm normalized name: D 1000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 IU vitamin D3 daily for 11 weeks
Trial: 17127226
Drug: Levofloxacin 250
RxNorm normalized name: levofloxacin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 250 mg oral, once daily (LVFX)
Trial: 17127226
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg oral, twice daily (CPFX)
Trial: 17127226
Drug: Placebo one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo one tablet oral once daily (P group)
Trial: 15023707
Drug: Mupirocin 2%
RxNorm normalized name: MUPIROCIN 2% OINT
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin 2% nasal ointment (n = 793)
Trial: 15023707
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment (n = 809)
Trial: 27163519
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens (CE) 0.45 or 0.625 mg/Bazedoxifene (BZA) 20 mg
Trial: 21459785
Drug: Dialysate calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate calcium concentration of 1.12 mmol/L
Trial: 21459785
Drug: Dialysate calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate calcium concentration of 1.37 mmol/L
Trial: 18089701
Drug: Calcium 1200
RxNorm normalized name: Premier Value Calcium 1200 + D3 Extended-Release Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 1200 mg/d with placebo vitamin D (Ca group)
Trial: 18089701
Drug: Calcium 1200
RxNorm normalized name: Premier Value Calcium 1200 + D3 Extended-Release Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 1200 mg/d with 1000 IU/d vitamin D2 (CaD group)
Trial: 12906343
Drug: Selenium therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium therapy (200 microg/day)
Trial: 10715288
Drug: Paclitaxel at
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel at 175 mg/m(2) over 3 hours every 3 weeks
Trial: 10715288
Drug: Oxaliplatin at
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin at 130 mg/m(2) over 2 hours every 3 weeks
Trial: 1528969
Drug: Continuous venotonic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous venotonic treatment for one month
Trial: 1528969
Drug: Intermittent venotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent venotonic treatment in parallel with active contraceptive treatment from the 10th to the 28th day
Trial: 7449633
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg isosorbide dinitrate (10 subjects)
Trial: 7449633
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg prazosin (20 subjects)
Trial: 7449633
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg dihydralazine (8 subjects)
Trial: 31141099
Drug: Low socioeconomic
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low socioeconomic status (L-SES)
Trial: 27916286
Drug: Relating Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relating Therapy (RT)
Trial: 23567399
Drug: Peaceful Mind
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peaceful Mind intervention (up to 12 weekly in-home sessions and up to eight brief telephone sessions)
Trial: 22176903
Drug: Montelukast sodium
RxNorm normalized name: Montelukast Sodium
DrugBank: Montelukast (DB00471)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Montelukast sodium (5 mg) for 12 weeks
Trial: 19475468
Drug: Bilateral infraorbital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral infraorbital injections with 0.5% bupivacaine (Group IOB)
Trial: 14597937
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (conjugated estrogens and medroxyprogesterone)
Trial: 10400007
Drug: Enalapril +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril + Aspirin
Trial: 7271091
Drug: Minocycline 100
RxNorm normalized name: minocycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 100 mg once daily for 7 days
Trial: 7271091
Drug: Minocycline 100
RxNorm normalized name: minocycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 100 mg once daily for 21 days
Trial: 31201476
Drug: Dopamine receptor
RxNorm normalized name: Dopamine receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine receptor agonist, pramipexole 0.5 mg
Trial: 31201476
Drug: Dopamine receptor
RxNorm normalized name: Dopamine receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine receptor antagonist, amisulpride 400 mg
Trial: 18443258
Drug: ACEIs or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEIs or angiotensin receptor blockers
Trial: 8844718
Drug: Fructo-oligosaccharides (FOS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructo-oligosaccharides (FOS) 12.5 g/day
Trial: 1739571
Drug: Bupivacaine 2
RxNorm normalized name: bupivacaine 29.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2 mg kg‐1 with adrenaline 1 in 200,000 plus hyaluronidase 3000 iu
Trial: 1739571
Drug: Bupivacaine 2
RxNorm normalized name: bupivacaine 29.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2 mg kg‐1 with adrenaline 1 in 200,000 without hyaluronidase
Trial: 6371788
Drug: Zaditen syrup
RxNorm normalized name: Zaditen
DrugBank: Ketotifen (DB00920)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zaditen syrup
Trial: 24561494
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg daily pravastatin
Trial: 22322521
Drug: Articaine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Articaine (40 mg with Epinephrine 0.5 mg %)
Trial: 22322521
Drug: Articaine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Articaine (40 mg with Epinephrine 1 mg %)
Trial: 22322521
Drug: Mepivacaine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine (30 mg with Epinephrine 1 mg %)
Trial: 22322521
Drug: Mepivacaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine (20 mg with Epinephrine 1 mg %)
Trial: 20850004
Drug: Intravenous artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous artesunate 2·4 mg/kg at 0, 12, and 24 hours, then daily
Trial: 20850004
Drug: Intravenous quinine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous quinine 20mg/kg initially then 10mg/kg three times a day
Trial: 17550648
Drug: Diethylcarbamazine (DEC)
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (DEC) alone (6 mg/kg)
Trial: 17550648
Drug: Diethylcarbamazine (DEC)
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (DEC) combined with Albendazole (ALB) (400 mg)
Trial: 15370010
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg daily, with daily dispensing for the first 7 days and weekly dispensing for the following 11 weeks
Trial: 11372045
Drug: PGV (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGV (cisplatin 50 mg/m², gemcitabine 1000 mg/m², vinorelbine 25 mg/m²)
Trial: 11372045
Drug: PGT (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGT (cisplatin 50 mg/m², gemcitabine 1000 mg/m², paclitaxel 125 mg/m²)
Trial: 11372045
Drug: PG (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PG (cisplatin 100 mg/m², gemcitabine 1000 mg/m²)
Trial: 9215189
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg vaginal prostaglandin E2 gel
Trial: 9215189
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg intracervical prostaglandin E2 gel
Trial: 25500488
Drug: Liposomal curcumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal curcumin (10 - 400 mg/m2)
Trial: 25500488
Drug: Liposomal curcumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal curcumin (≥ 120 mg/m2)
Trial: 25500488
Drug: Liposomal curcumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal curcumin (up to 120 mg/m2)
Trial: 18514162
Drug: 0.67 mg/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.67 mg/L solution
Trial: 18514162
Drug: 5.45 mg/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.45 mg/L solution
Trial: 16817039
Drug: Cyclic etidronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclic etidronate therapy (oral regimen repeated every 14 weeks)
Trial: 10618952
Drug: Saline dilution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline dilution (20% with 0.9% saline, 1 ml)
Trial: 10618952
Drug: Aspirin (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (375 mg daily for 3 days)
Trial: 7488989
Drug: Palliative-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palliative-treatment
Trial: 1903558
Drug: misoprostol, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: misoprostol, 400 micrograms twice daily
Trial: 1903558
Drug: high‐dose liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: high‐dose liquid antacid regimen
Trial: 27722224
Drug: Immediate post-extractive
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate post-extractive ultra-wide 7 mm-diameter implants (group A)
Trial: 27722224
Drug: Delayed implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed implant installation 4 months after tooth extraction and socket preservation (group B)
Trial: 20336635
Drug: Estrogen‐plus‐progestin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen‐plus‐progestin therapy (CHT)
Trial: 16028129
Drug: Therapeutic vaccines
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic vaccines (ALVAC-HIV [vCP1452] or ALVAC-HIV and Remune)
Trial: 11796648
Drug: Ranitidine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (75 mg)
Trial: 7749166
Drug: Navoban (tropisetron)
RxNorm normalized name: benzocaine / trimethobenzamide hydrochloride Rectal Suppository [Navogan]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Navoban (tropisetron) 5 mg once daily
Trial: 7749166
Drug: Navoban (tropisetron)
RxNorm normalized name: benzocaine / trimethobenzamide hydrochloride Rectal Suppository [Navogan]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Navoban (tropisetron) 10 mg once daily
Trial: 7749166
Drug: Dexamethasone (Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (Day 1, 0.2 mg/kg i.v.; Days 2-6, 8 mg p.o.)
Trial: 7749166
Drug: Alizapride (Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alizapride (Day 1, 100 mg i.v. and 4 x 50 mg p.o.; Days 2-6, 4 x 5 mg p.o.)
Trial: 30131296
Drug: Inhaled normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled normal saline (placebo)
Trial: 27827358
Drug: Aromatase inhibitors
RxNorm normalized name: Aromatase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromatase inhibitors (AIs) treatment
Trial: 20146631
Drug: elvitegravir 50
RxNorm normalized name: Elvitegravir
DrugBank: Elvitegravir (DB09101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: elvitegravir 50 mg
Trial: 20146631
Drug: elvitegravir 125
RxNorm normalized name: Elvitegravir
DrugBank: Elvitegravir (DB09101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: elvitegravir 125 mg
Trial: 2246794
Drug: Cognitive Marital
RxNorm normalized name: barbital
DrugBank: Barbital (DB01483)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Marital Therapy
Trial: 29127575
Drug: Bright white
RxNorm normalized name: PROPOLIS EXTRACT 7 g in 140 g / MENTHA PIPERITA (PEPPERMINT) STEM EXTRACT 1.4 g in 140 g / CHRYSANTHELLUM INDICUM FLOWER OIL 1.4 g in 140 g ORAL PASTE [BARUBT Probiotics Bright White Tooth-Paste]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright white light (BWL) therapy for 30 minutes daily for 28 days
Trial: 29127575
Drug: Dim red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dim red light (DRL) therapy for 30 minutes daily for 28 days
Trial: 21332628
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg plus statin (EZE/statin)
Trial: 18362594
Drug: Melatonin (3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (3.0 mg)
Trial: 17174195
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg NM-702
Trial: 17174195
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg NM-702
Trial: 17174195
Drug: NM-702 (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NM-702 (both doses)
Trial: 14702886
Drug: Postpartum mood
RxNorm normalized name: BluesAway Postpartum Mood Support Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postpartum mood disorder treatments (specific treatments not detailed in the abstract)
Trial: 10879333
Drug: Substance abuse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substance abuse treatment with prenatal care
Trial: 9487448
Drug: Regimen I
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen I (2EHRZ7/6EH7): 8-month daily regimen of ethambutol, isoniazid, rifampicin, and pyrazinamide for 2 months, followed by ethambutol and isoniazid for 6 months.
Trial: 9487448
Drug: Regimen II
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen II (2EHRZ2/4EHR2): 6-month twice-weekly regimen with the same four drugs for 2 months, followed by ethambutol, rifampicin, and isoniazid for 4 months.
Trial: 8238493
Drug: High insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High insulin infusion (3,620 +/‐ 476 pM)
Trial: 3552204
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of cyclophosphamide
Trial: 3552204
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of cyclophosphamide
Trial: 30312165
Drug: Herbal decoction
RxNorm normalized name: Hyperici herba
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal decoction (180 mL of Cassia fistula L pod's pericarp and Myristica fragrans Houtt arils)
Trial: 30312165
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid (500 mg orally twice daily)
Trial: 12871321
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (n = 357; opposed (n = 290) and unopposed (n = 67))
Trial: 12871321
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control group, n = 362)
Trial: 10741256
Drug: Semax administered
RxNorm normalized name: semax
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semax administered intransally as nasal drops
Trial: 10741256
Drug: Semax administered
RxNorm normalized name: semax
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semax administered by endonasal electrophoresis
Trial: 6384851
Drug: Antifibrinolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antifibrinolytic therapy (tranexamic acid)
Trial: 6384851
Drug: No antifibrinolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antifibrinolytic therapy (Control)
Trial: 26980919
Drug: Flurbiprofen spray
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen spray (3 times daily)
Trial: 26980919
Drug: Placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo solution (3 times daily)